A comparative study on the diversity of clinical features between the sero-negative and sero-positive rheumatoid arthritis patients

Rheumatology International

Volumn 32, Issue 12, 2012, Pages 3897-3901

  Geng, Yan ^a   Zhou, Wei ^a   Zhang, Zhuoli ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Clinical feature; Rheumatoid arthritis; Sero negative; Sero positive

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD CELL COUNT; BONE EROSION; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DAS28; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAND RADIOGRAPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; SWOLLEN JOINT COUNT; TENDER JOINT COUNT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BONE AND BONES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 84872264441     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2329-5     Document Type: Article

References (19)

1. Bukhari M et al (2001) Time to first occurrence of erosions in inflammatory polyarthritis: Results from a prospective community-based study. Arthr Rheum 44:1248-1253
2. Nell VP et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731-1736
3. Edelman J, Russell AS (1983) A comparison of patients with seropositive and seronegative rheumatoid arthritis. Rheumatol Int 3:47-48
4. Suzuki K et al (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197-204
5. Van der Helm-van Mil AH et al (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthr Res Ther 7:R949-R958
6. De Rycke L et al (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: Diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63:1587-1593
7. Chen R et al (2007) Clinical and laboratory features of rheumatoid arthritis that has negative serum autoantibodies. Chin J Rheumatol 11:466-468
8. Korkmaz C et al (2006) Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem 39:961-965
9. Sahatciu-Meka V et al (2010) Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis. Bosn J Basic Med Sci 10:26-31
10. Ikeda E et al (1998) Rheumatoid vasculitis in a patient with seronegative rheumatoid arthritis. Eur J Dermatol 8:268-270
11. Carr CS, Roxburgh JC (1999) Heart valve disease in seronegative rheumatoid arthritis. J R Soc Med 92:531-532
12. Bongartz T et al (2007) Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 46: 70-75
13. van Zeben D et al (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: Results of a follow up study. Ann Rheum Dis 51:1029-1035
14. Greiner A et al (2005) Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann NY Acad Sci 1050:295-303
15. Li H et al (2010) Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29:413-417
16. Shovman O et al (2005) The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clin Dev Immunol 12:197-202
17. Quinn MA et al (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford) 45:478-480
18. van Dongen H et al (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial. Arthr Rheum 56:1424-1432
19. Shin YS et al (2005) Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. Yonsei Med J 46: 464-470